首页> 外文期刊>RSC Advances >Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors
【24h】

Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors

机译:作为抗肿瘤PARP-1抑制剂的新喹唑啉酮衍生物的设计,合成和硅研究

获取原文
获取原文并翻译 | 示例
           

摘要

Herein, we report an eco-friendly synthesis of a new series of quinazolinone-based derivatives as potential PARP-1 inhibitors. The 4-quinazolinone scaffold was utilized as a bioisostere to the phthalazinone core of the reference compound Olaparib. Most of the synthesized compounds displayed appreciable inhibitory activity against PARP1. Compound 12c showed inhibitory activity at IC50 = 30.38 nM comparable to Olaparib, which has IC50 = 27.89 nM. Cell cycle analysis was performed for compounds 12a and 12c, and both exhibited cell growth arrest at G2/M phase in the MCF-7 cell line. In addition, both compounds increased the programmed apoptosis compared to the control. Furthermore, molecular docking of the final compounds into the PARP-1 active site was executed to explore their probable binding modes. Also, a computational QSAR and in silico ADMET study was performed. The results of this study revealed that some of the newly synthesized compounds could serve as a new framework to discover new PARP-1 inhibitors with anti-cancer activity.
机译:在此,我们报告了一种环保合成的新系列基于喹唑啉基衍生物作为潜在的PARP-1抑制剂。 4-喹唑啉酮支架用作参考化合物奥拉帕里氏植物的生物偏见的生物纤维素核。大多数合成化合物对PARP1显示出明显的抑制活性。化合物12c在IC50 = 30.38nm的抑制活性与olaparib相当,其具有IC50 = 27.89nm。对化合物12a和12c进行细胞循环分析,并且在MCF-7细胞系中的G2 / M相显示细胞生长停滞。此外,与对照相比,两种化合物都增加了编程的细胞凋亡。此外,对最终化合物的分子对接进入PARP-1活性位点以探讨其可能的结合模式。此外,进行了计算QSAR和Silico备用备用研究。该研究的结果显示,一些新合成的化合物可以作为发现具有抗癌活动的新PARP-1抑制剂的新框架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号